JNJ | Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA | NYSE

Index	DJIA, S&P 500	P/E	33.47	EPS (ttm)	4.78	Insider Own	0.10%	Shs Outstand	2.61B	Perf Week	1.94%
Market Cap	409.39B	Forward P/E	14.55	EPS next Y	11.00	Insider Trans	-0.64%	Shs Float	2.60B	Perf Month	-1.01%
Income	12.72B	PEG	7.71	EPS next Q	2.62	Inst Own	70.80%	Short Float / Ratio	0.52% / 1.87	Perf Quarter	5.54%
Sales	96.26B	P/S	4.25	EPS this Y	-13.70%	Inst Trans	-0.37%	Short Interest	13.48M	Perf Half Y	-9.69%
Book/sh	27.20	P/B	5.88	EPS next Y	3.22%	ROA	6.90%	Target Price	179.71	Perf Year	-9.74%
Cash/sh	9.62	P/C	16.63	EPS next 5Y	4.34%	ROE	17.00%	52W Range	150.11 - 183.35	Perf YTD	-9.42%
Dividend	4.76	P/FCF	93.68	EPS past 5Y	5.30%	ROI	15.40%	52W High	-12.73%	Beta	0.54
Dividend %	2.97%	Quick Ratio	0.90	Sales past 5Y	4.40%	Gross Margin	67.00%	52W Low	6.60%	ATR	2.02
Employees	152700	Current Ratio	1.10	Sales Q/Q	5.60%	Oper. Margin	15.70%	RSI (14)	56.58	Volatility	1.23% 1.26%
Optionable	Yes	Debt/Eq	0.75	EPS Q/Q	-101.40%	Profit Margin	13.20%	Rel Volume	0.87	Prev Close	160.26
Shortable	Yes	LT Debt/Eq	0.49	Earnings	Apr 18 BMO	Payout	93.20%	Avg Volume	7.20M	Price	160.01
Recom	2.40	SMA20	1.52%	SMA50	-0.24%	SMA200	-3.20%	Volume	6,231,994	Change	-0.16%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185
Dec-17-21	Initiated	Goldman	Neutral	$161
Dec-15-21	Reiterated	Citigroup	Buy	$192 → $195
Sep-07-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$187
May-28-21	Resumed	Morgan Stanley	Overweight	$187
Apr-28-20	Downgrade	UBS	Buy → Neutral	$163 → $160
Apr-22-20	Upgrade	BofA/Merrill	Neutral → Buy	$150 → $175
Mar-05-20	Initiated	Citigroup	Buy	$163
Dec-19-19	Upgrade	Barclays	Equal Weight → Overweight	$173
Dec-17-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $170

Show Previous Ratings

Jun-10-23 05:30AM	Blue Chip Bargain Hunting: 2 Top Stocks to Buy Now (Motley Fool)
Jun-09-23 02:08PM	Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It (The Wall Street Journal)
09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
Jun-08-23 05:42PM	10 Reliable Dividend Stocks Billionaires Are Loading Up On (Insider Monkey)
04:13PM	15 Healthcare Stocks Billionaires Are Loading Up On (Insider Monkey)
07:00AM	Loading…
07:00AM	Investors in Johnson & Johnson (NYSE:JNJ) have seen favorable returns of 48% over the past five years (Simply Wall St.)
Jun-07-23 12:31PM	Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View (Zacks)
07:25AM	Top 16 Dividend Stocks To Buy According To Hedge Funds (Insider Monkey)
05:21AM	3 No-Brainer Stocks to Buy With $300 Right Now (Motley Fool)
Jun-06-23 04:30PM	Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results (Business Wire)
03:50PM	Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements (Benzinga)
10:16AM	Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Years Biggest IPO (Bloomberg)
05:46AM	20 Most Respected Professions in the World (Insider Monkey)
Jun-05-23 05:45PM	Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know (Zacks)
12:45PM	25 S&P 500 Dividend Aristocrats To Avoid (Insider Monkey)
11:13AM	Loading…
11:13AM	Analyst Report: Johnson & Johnson (Morningstar Research)
06:14AM	Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast (Reuters)
Jun-04-23 01:29PM	10 Dementia Medications that are Approved or in Clinical Trials (Insider Monkey)
10:15AM	2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip (Motley Fool)
07:36AM	1 Ultra-Elite Dividend Stock to Buy Hand Over Fist in June (Motley Fool)
06:43AM	2 Warren Buffett Stocks to Buy in June and Hold Forever (Motley Fool)
Jun-03-23 10:45AM	The Little-Known Secret to Beating the S&P 500 (Motley Fool)
08:00AM	With 65% ownership, Johnson & Johnson (NYSE:JNJ) boasts of strong institutional backing (Simply Wall St.)
05:19AM	Two Dow Stocks to Buy in June and Hold for the Next Decade (Motley Fool)
Jun-02-23 11:55AM	S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Popularity (Insider Monkey)
11:49AM	14 Best Annual Dividend Stocks To Buy Now (Insider Monkey)
10:59AM	LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection (Zacks)
08:32AM	3 High-Quality Dividend Stocks Yielding 3% to Buy in June (Motley Fool)
Jun-01-23 06:24PM	US FDA revokes emergency use authorization for J&J's COVID vaccine (Reuters)
05:39PM	UPDATE 1-J&J secures dismissal of whistleblower case over misuse of confidential info (Reuters)
04:37PM	Loading…
04:37PM	J&J secures dismissal of whistleblower case over misuse of confidential info (Reuters)
04:32PM	REFILE-J&J secures dismissal of whistleblower case over misuse of confidential info (Reuters)
11:48AM	Johnson & Johnson Back in Court Over Talc-Related Cancer Claims (Benzinga)
10:04AM	15 Best Healthcare Stocks To Buy Now (Insider Monkey)
09:45AM	Is It Too Early to Invest In Nano-X Imaging? (Motley Fool)
09:05AM	2 Dow Stocks to Buy More of in June (Motley Fool)
05:37AM	3 Reliable Dividend Growth Stocks to Buy Hand Over Fist in June (Motley Fool)
05:06AM	3 Warren Buffett Stocks That Are Screaming Buys in June (Motley Fool)
04:57AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis (Zacks)
May-31-23 05:11PM	UPDATE 1-J&J faces new trial over talc cancer claims, amid settlement push (Reuters)
04:26PM	Obesity Shot Frenzy Makes Eli Lilly Worlds Most Valuable Drugmaker (Bloomberg)
03:45PM	J&J faces new trial over talc cancer claims, amid settlement push (Reuters)
12:09PM	Bristol Myers' (BMY) Lung Cancer Drug NDA Gets Priority Review (Zacks)
09:42AM	5 Large Drug Stocks to Watch From a Thriving Industry (Zacks)
06:00AM	Future Fortune 500 CEOs: 11 up-and-comers that leadership experts see as generational standout bosses (Fortune)
12:09AM	Best Of: Inside Johnson & Johnsons bankruptcy two-step (Financial Times)
May-30-23 05:45PM	Johnson & Johnson (JNJ) Stock Moves 0.01%: What You Should Know (Zacks)
01:06PM	The Argus ESG Model Portfolio (Argus Research)
06:15AM	The Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCare (Zacks)
May-29-23 09:00AM	Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock (Zacks)
08:00AM	Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly (Simply Wall St.)
May-28-23 11:09AM	ChatGPT Stock Portfolio: Top 10 Picks (Insider Monkey)
10:30AM	Bearish Bets: 3 Stocks You Should Really Consider Shorting This Week (TheStreet.com)
05:30AM	Buy the Dip On These Warren Buffett Stocks (Motley Fool)
May-26-23 04:12PM	Tylenol-Maker Kenvue Poised to Get Wall Street Ratings After IPO (Bloomberg)
12:32PM	Bristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation (Zacks)
09:53AM	Want Passive Income Forever? Buy These 2 Magnificent Stocks Now (Motley Fool)
09:51AM	Solid Earnings Fuel Potential Bull Market in Medical Devices (Zacks)
05:30AM	A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know. (Motley Fool)
May-25-23 12:22PM	Just 2 AAA-Rated Companies Remain As U.S. Risks Being A Deadbeat (Investor's Business Daily)
09:00AM	Is There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 22% Undervaluation? (Simply Wall St.)
May-24-23 05:45PM	Johnson & Johnson (JNJ) Stock Moves -0.1%: What You Should Know (Zacks)
09:33AM	14 Best Healthcare Dividend Stocks to Buy (Insider Monkey)
05:30AM	Better Buy: Medtronic vs. Johnson & Johnson (Motley Fool)
May-23-23 07:51PM	Debt-Ceiling Fight Sends Investors Hunting for New Havens (The Wall Street Journal)
11:01AM	UPDATE 2-Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara (Reuters)
10:29AM	Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara (Reuters)
10:07AM	Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash (Motley Fool)
May-21-23 11:50AM	12 Cheap Dividend Stocks With High Yields (Insider Monkey)
06:04AM	Got $1,000? 5 Buffett Stocks to Buy and Hold Forever (Motley Fool)
May-20-23 06:14AM	3 Relatively Safe Stocks to Buy if a Recession Is on the Way (Motley Fool)
May-19-23 05:24AM	Kenvue Just IPO'd, but Is the Stock a Buy? (Motley Fool)
May-18-23 11:50AM	Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15 (InvestorPlace)
11:30AM	Johnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound? (Zacks)
07:13AM	7 High-Quality Dow Stocks to Buy on the Dip (InvestorPlace)
07:00AM	10 Best Stocks to Buy According to Billionaire Paul Tudor Jones (Insider Monkey)
06:20AM	3 Reliable Dividend Stocks That Fit in Any Investors Portfolio (InvestorPlace)
May-17-23 12:55PM	Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears (TipRanks)
10:20AM	Johnson & Johnson Sets Aside $400M To End US State Consumer Protection Claims (Benzinga)
08:35AM	2 Dividend Stocks to Double Up On Right Now (Motley Fool)
06:05AM	Should Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend? (Simply Wall St.)
05:21AM	3 No-Brainer Stocks to Buy With $1,000 Right Now (Motley Fool)
05:10AM	Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows (Motley Fool)
05:08AM	AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial (Reuters)
May-16-23 11:57AM	J&J's proposed talc settlement would pay $400 million to US state AGs (Reuters)
09:38AM	Kenvue Has Gone Public: Should You Buy the Stock? (Motley Fool)
09:10AM	Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group? (Motley Fool)
09:00AM	Is Trending Stock Johnson & Johnson (JNJ) a Buy Now? (Zacks)
May-15-23 07:00AM	Johnson & Johnson's (NYSE:JNJ) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? (Simply Wall St.)
May-13-23 08:55AM	2 No-Brainer Healthcare Stocks to Buy Right Now (Motley Fool)
May-12-23 06:48PM	25 Best US Cities for People With Allergies (Insider Monkey)
03:14PM	Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment (Benzinga)
12:43PM	How Apple Pleased Investors (Motley Fool)
11:15AM	Eli Lilly on Pace to Top Johnson & Johnson's Market Cap (The Wall Street Journal)
11:10AM	Eli Lilly's Market Cap Could Surpass J&J's for First Time Since 1997 (Barrons.com)
09:47AM	STERIS (STE) Q4 Earnings Beat Estimates, Gross Margin Falls (Zacks)
08:32AM	Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates (Zacks)
May-11-23 04:27PM	The Surprising Reason Nanox Stock Jumped Again Today (Motley Fool)
02:00PM	3 Healthcare Stocks to Buy and Hold for the Next 10 Years (Motley Fool)
01:51PM	Warren Buffetts $5.7 Billion Dividend Portfolio: Top 15 Picks (Insider Monkey)

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Swanson James D.	See Remarks	Mar 06	Sale	154.66	1,062	164,199	9,215	Mar 08 04:16 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Feb 10	Option Exercise	0.00	2,999	0	44,812	Feb 14 04:36 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 10	Option Exercise	0.00	3,570	0	130,026	Feb 14 04:36 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 10	Option Exercise	0.00	5,220	0	300,940	Feb 14 04:37 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 10	Option Exercise	0.00	2,078	0	116,754	Feb 14 04:35 PM
Mongon Thibaut	Exec VP, WW Chair, Cons Health	Feb 10	Option Exercise	0.00	2,285	0	59,461	Feb 14 04:35 PM
Hait William	See Remarks	Feb 10	Option Exercise	0.00	3,856	0	84,092	Feb 14 04:35 PM
Wolk Joseph J	Exec VP, CFO	Feb 10	Option Exercise	0.00	3,449	0	39,261	Feb 14 04:36 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 10	Option Exercise	0.00	1,807	0	73,118	Feb 14 04:37 PM
Swanson James D.	See Remarks	Feb 10	Option Exercise	0.00	1,291	0	8,355	Feb 14 04:34 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 10	Option Exercise	0.00	1,592	0	17,259	Feb 14 04:35 PM
Decker Robert J	VP Corporate Controller	Feb 10	Option Exercise	0.00	581	0	16,054	Feb 14 04:35 PM
Gorsky Alex	Director	Jan 17	Option Exercise	72.54	547,692	39,729,578	1,133,194	Jan 18 04:39 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 17	Option Exercise	72.54	148,538	10,774,947	394,515	Jan 18 04:39 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Option Exercise	88.19	14,781	1,303,589	50,593	Dec 15 04:34 PM
Wolk Joseph J	Exec VP, CFO	Dec 13	Sale	179.60	14,781	2,654,661	35,812	Dec 15 04:34 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Nov 30	Option Exercise	72.54	73,323	5,318,850	115,136	Dec 02 04:32 PM
McEvoy Ashley	EVP, WW Chair, MedTech	Nov 30	Sale	175.47	73,323	12,865,801	41,813	Dec 02 04:32 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Nov 22	Option Exercise	72.54	76,923	5,579,994	203,379	Nov 23 04:44 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Nov 22	Sale	176.78	76,923	13,598,402	126,456	Nov 23 04:44 PM
Decker Robert J	Controller, CAO	Nov 18	Option Exercise	90.44	16,928	1,530,968	32,401	Nov 21 04:33 PM
Decker Robert J	Controller, CAO	Nov 18	Sale	175.00	16,928	2,962,400	15,473	Nov 21 04:33 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Nov 09	Option Exercise	72.54	16,410	1,190,381	87,721	Nov 10 04:47 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Nov 09	Sale	173.42	16,410	2,845,773	71,311	Nov 10 04:47 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 07	Option Exercise	109.99	17,043	1,874,626	57,176	Nov 09 05:01 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 04	Option Exercise	130.77	35,246	4,609,161	75,379	Nov 08 04:59 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Nov 04	Sale	171.18	35,246	6,033,305	40,133	Nov 08 04:59 PM
Swanson James D.	EVP, Chief Information Officer	Nov 02	Option Exercise	0.00	9,912	0	10,996	Nov 04 04:30 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Option Exercise	115.67	78,458	9,075,237	193,134	Oct 26 07:20 PM
Hait William	See Remarks	Oct 24	Option Exercise	90.44	15,000	1,356,600	95,236	Oct 26 04:51 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.36	29,275	5,016,623	114,676	Oct 26 07:21 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.19	20,851	3,569,558	143,951	Oct 26 07:21 PM
Hait William	See Remarks	Oct 24	Sale	171.55	15,000	2,573,220	80,236	Oct 26 04:51 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.22	12,998	2,225,554	164,802	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.14	8,256	1,412,940	177,800	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.13	4,263	729,520	184,856	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 24	Sale	171.02	2,815	481,429	188,719	Oct 26 07:20 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Option Exercise	101.87	70,126	7,143,736	184,802	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	29,946	4,926,207	136,240	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	22,864	3,761,197	114,676	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	13,703	2,254,185	167,486	Oct 21 04:31 PM
Fasolo Peter	Exec VP, Chief HR Officer	Oct 19	Sale	164.50	3,613	594,349	181,189	Oct 21 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ | Johnson & Johnson

Upgrade your FINVIZ experience